December 2025 European Stocks That May Be Trading Below Fair Value

Simply Wall St

Mon, December 15, 2025 at 12:37 AM EST 4 min read

As of December 2025, the European stock market has shown mixed performance, with indices like Germany’s DAX seeing gains while others such as France’s CAC 40 have experienced declines. Amidst potential rate hikes from the European Central Bank and economic resilience in the region, investors are keenly searching for stocks that might be trading below their fair value. Identifying undervalued stocks can offer opportunities for investors to capitalize on discrepancies between a company’s market price and its intrinsic worth, particularly in a fluctuating economic landscape.

Click here to see the full list of 192 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

Overview: Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company that manufactures, sells, and markets its products in Spain, the European Union, OECD countries, and internationally with a market cap of €3.18 billion.

Operations: Laboratorios Farmaceuticos Rovi generates its revenue primarily through the manufacturing, sales, and marketing of pharmaceutical products across Spain, the European Union, OECD countries, and other international markets.

Estimated Discount To Fair Value: 37.9%

Laboratorios Farmaceuticos Rovi is trading at €62.25, significantly below its estimated fair value of €100.24, suggesting it may be undervalued based on cash flows. Despite a recent decline in sales to €525.06 million and net income to €97.77 million for the nine months ending September 2025, earnings are expected to grow substantially over the next three years at 21.3% annually, surpassing the Spanish market average growth rate of 7%.

• Our earnings growth report unveils the potential for significant increases in Laboratorios Farmaceuticos Rovi’s future results.

• Get an in-depth perspective on Laboratorios Farmaceuticos Rovi’s balance sheet by reading our health report here.

Overview: Apotea AB (publ) operates an online pharmacy in Sweden with a market capitalization of approximately SEK9.19 billion.